Psychedelics Today

Psychedelics Today
undefined
Aug 26, 2025 • 1h 5min

PT 622 - Matt Xavier - The Psychedelic DJ

From the Rave Scene to Psychedelic Therapy In this episode, Kyle Buller speaks with Matt Xavier, DJ, therapist, and author. The conversation took place live at Psychedelic Science. Matt recalls his early years in the rave culture of 1990s New York. He ran record labels, hosted psychedelic trance events, and lived through the intensity of that scene. Why Music Is Medicine Matt believes music should be treated as medicine. He explains how playlists can align with the stages of a psychedelic journey—onset, climb, peak, and descent. He encourages people to listen with intention and to categorize tracks by emotion, energy, and therapeutic impact. Psychedelic Soundtracking Instead of relying only on fixed playlists, Matt performs live mixing during sessions. This method keeps him fully engaged and responsive. He calls the approach “psychedelic soundtracking.” In his view, the guide becomes a tuning fork, adjusting the soundscape to match the client’s process. Key Themes in the Conversation The evolution from rave DJ to therapist and author How music amplifies psychedelics, and why it matters Matching music with each stage of a journey Differences between psilocybin, MDMA, and ketamine work The value of silence, long-form tracks, and harmonic mixing Why buying music supports artists and protects creativity from AI Practical tips for building playlists and rediscovering a love of listening Supporting Artists and Building Community Matt highlights the artists who inspire his work, from ambient pioneers to contemporary sound designers. He urges practitioners to support independent musicians by purchasing their music. In his words, keeping human creativity alive is essential for meaningful psychedelic work. Writing, Mixing, and the Future Matt also discusses his new book and the curated four-hour DJ protocol mix he designed for therapy sessions. He explains how this project grew into a collaborative effort and why writing became a spiritual journey for him. Looking ahead, he hopes to create a training program for others interested in weaving music into psychedelic practice. 🎶 Whether you are a therapist, a DJ, or simply a music lover, this episode shows how sound can transform the psychedelic experience.
undefined
Aug 21, 2025 • 1h 17min

PT 621 - Dr Case Newsom - Zendo Project

In this episode, Joe Moore sits down with Dr. Case Newsom, an emergency room physician in Denver and Medical Director for both Zendo Project and Stadium Medical. They explore how psychedelic harm reduction is merging with event medicine at concerts, festivals, and large-scale gatherings. Dr. Newsom shares his path from osteopathic medical training to bridging emergency medicine with psychedelic peer support. He explains how the Zendo Project has expanded beyond Burning Man, and why collaboration with medical teams matters. The discussion highlights new triage protocols, cultural shifts in Colorado, and the legal challenges that still stand in the way of safer events. Topics Covered The role of the Zendo Project: Peer support, harm reduction, and creating grounded spaces in chaotic environments. Stadium Medical’s model: Covering Denver’s biggest venues and connecting emergency care with psychedelic peer support. Developing medical triage protocols: A simple system that reduces unnecessary ER transports while ensuring sitter and guest safety. Colorado as a hub: Why Denver and Red Rocks are central to psychedelic culture and harm reduction innovation. Legal and regulatory challenges: The impact of the RAVE Act and limits on drug checking services. Research and data collection: Building stronger studies to show venues and first responders the value of harm reduction. Future concerns: Ibogaine’s cardiotoxic risks, the rise of AI-designed drugs, and why medical involvement is urgent. Ketamine in the ER: How ketamine provides pain relief and can create meaningful patient experiences when used with care.
undefined
Aug 18, 2025 • 1h 20min

PT 620 - Kat Murti – Students for Sensible Drug Policy, Meta Censorship, and the Fight for Science

In this episode, Joe Moore is joined by Kat Murti, Executive Director of Students for Sensible Drug Policy (SSDP), the largest youth-led network working to end the war on drugs. SSDP organizes at the campus, local, state, federal, and international levels, with more than 100 chapters across the U.S. and sister organizations worldwide. Kat shares her personal journey into drug policy reform, from witnessing DEA raids on AIDS patients in the 1990s to fighting for civil liberties as a student at UC Berkeley. She explains how SSDP empowers young people to challenge outdated laws and promote policies rooted in compassion, scientific evidence, and human rights. Topics Discussed The War on Drugs as a War on Us: Kat’s early realizations about the drug war’s racism, injustice, and destruction of civil liberties. Her Path to SSDP: From working on California’s Prop 19 cannabis campaign to serving on SSDP’s board and eventually becoming Executive Director. Meta Censorship Campaign: Why Meta’s restrictions on drug education and harm reduction content harm communities, and how SSDP is organizing public pressure to protect freedom of information online. Forced Institutionalization & Executive Orders: Kat critiques recent federal moves to expand forced treatment, cuts to naloxone training programs, and the misguided use of tariffs as “solutions” to the overdose crisis. The Fight Against DEA Scheduling of DOI & DOC: Why these research chemicals are vital to neuroscience and medicine, how SSDP challenged the DEA in court, and what’s at stake for future research. Illogical Drug Policy & Careerism: How prohibition persists due to political incentives, propaganda, and entrenched bureaucratic interests. Building a Better Future: Realigning incentive structures, embracing harm reduction, and supporting community-based solutions to drug use. Key Takeaways The war on drugs is deeply racist, anti-science, and erodes civil liberties. Meta’s censorship of harm reduction information actively endangers lives. Forced treatment doesn’t work—addressing social conditions and providing safe housing does. DOI and DOC, rarely if ever used recreationally, are critical to medical research, and scheduling them would halt decades of progress. Real reform means both ending prohibition and creating environments where people feel supported, connected, and empowered. Links & Resources Students for Sensible Drug Policy (SSDP): ssdp.org Kat Murti on Twitter/X: @KatMurti Kat Murti on Instagram: @KittyRevolution SSDP Petition against Meta Censorship: ssdp.org
undefined
Jul 31, 2025 • 1h 9min

PT 619 - Sphinx Gate with Mareesa Stertz and Tania Abdul

Mareesa Stertz and Tania Abdul, the visionaries behind the ambitious Sphinx Gate project for Burning Man 2025, delve into how art and play can fuel personal and collective transformation. They share insights on the mythical inspiration from The NeverEnding Story and the evolving experience of self-discovery through immersive installations. The duo discusses the importance of community co-creation, emotional exploration, and envisioning future traveling art that fosters joy and integration, making the Sphinx Gate a transformative journey for all.
undefined
Jul 29, 2025 • 1h 14min

PT 618 - Chad Charles - Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices

Chad Charles, an educator and practitioner with nearly a decade of experience in 5-MeO-DMT therapy, shares his expertise on integrating this powerful substance into therapeutic settings. He emphasizes the need for thorough practitioner training and the importance of personalized therapeutic alliances. Chad discusses the ethical complexities around dosing, informed consent, and the significance of a trauma-informed approach. Additionally, he introduces his upcoming research project analyzing over 500 sessions to uncover best practices and enhance harm reduction in the psychedelic space.
undefined
Jul 24, 2025 • 1h 15min

PT 617 - Alan Davis - Psychedelic Research and Patient Safety at Ohio State & Exploring Ibogaine's Potential

In a deep dive into psychedelic research, Alan Davis, an Associate Professor at Ohio State University, discusses the evolving potential of Ibogaine, focusing on its therapeutic benefits for substance use disorders. He highlights the groundbreaking Iboga Patient Survey, emphasizing the necessity of rigorous, real-world safety data. Alan also tackles the challenges of clinical trials, the interplay between ethical practices and corporate interests, and the specific needs of veterans facing trauma. Their conversation is both informative and thought-provoking, shedding light on the future of psychedelic medicine.
undefined
Jul 22, 2025 • 1h 6min

PT 616 - Karina Bashir on Psychedelics, Islam, and Human Rights

In this enlightening discussion, attorney Karina Bashir shares her journey from human rights advocacy to the field of psychedelic law. She explores the intersection of psychedelics and Islam, including insights from her presentation at Harvard. Karina discusses the potential of psychedelics to enhance mental health within marginalized communities and the legal challenges faced in this evolving space. She highlights Sufism's spiritual depth and the need for ethical frameworks while advocating for access to psychedelic medicine for Muslim communities, bridging tradition and modern healing.
undefined
Jul 18, 2025 • 1h 21min

PT 615 - Kristen Nash and Erica Siegel on Risk Reduction and Psychedelic Safety

Kristen Nash, founder of the Coalition for Psychedelic Safety and Education, shares her tragic journey after losing her son in a psychedelic-related incident. Erica Siegel, founder of Nest Harm Reduction, emphasizes trauma-informed, peer-based support in psychedelic therapy. They discuss the critical importance of risk reduction, the dangers of glorifying psychedelics without context, and the need for comprehensive education, especially for Gen Z users. Together, they advocate for ethical practices, community collaboration, and a focus on psychological safety in psychedelic use.
undefined
Jul 15, 2025 • 1h 19min

PT 614 - Erica Rex: Scientific Integrity, Psychedelic Research, and the Religious Leader Study

Erica Rex, an award-winning science journalist and author of the forthcoming book 'Seeing What Is There', discusses her experiences in psychedelic research, particularly her participation in a landmark psilocybin study. She dives into the goals and ethical challenges of the Religious Leader Study, exploring how psilocybin impacts religious figures. The conversation critiques the methodology and rigor in psychedelic science, emphasizing the disconnect between spiritual experiences and academic research. Rex advocates for a more inclusive approach to understanding consciousness.
undefined
Jul 8, 2025 • 1h 9min

PT 613 - Daniel Pinchbeck - From Cultural Catalyst to Capitalist Co-optation: Reflections on Psychedelic Science, AI, and Idealist Monism

In this expansive episode of Psychedelics Today, Joe Moore sits down with author and cultural theorist Daniel Pinchbeck to explore the evolving—and increasingly contested—role of psychedelics in society. From the hopeful spirit of transformation that animated earlier psychedelic movements to the sobering reality of biotech, branding, and political entanglement, Daniel offers a candid diagnosis of where we are—and where we might be headed. Reflecting on Psychedelic Science 2025, Daniel discusses the event’s stark shift toward commercialization and industry influence. He contrasts this with his earlier work on Evolver, a movement that sought to integrate psychedelics with permaculture, alternative economics, and cultural awakening. Together, Joe and Daniel examine how the field’s idealistic origins have been increasingly subjected to capitalist co-option. They also dive into deeper philosophical terrain—discussing monistic idealism, Rudolf Steiner, and the suppression of mystical and paranormal dimensions in the push to medicalize and sanitize psychedelics for mainstream acceptance. Daniel warns of the dangers of ignoring the shadow, including psychic fragmentation and what he calls "entity attachment" from ungrounded use. The conversation ranges from tech billionaires on ketamine to the geopolitical threat of authoritarianism, the weaponization of AI, and the quiet complicity of many in the psychedelic space who avoid political engagement. Daniel shares his current projects, including his Substack newsletter and a new seminar, Breaking the AI Barrier. This is a timely, unflinching exploration of psychedelics as both medicine and mirror—revealing the best and worst of our collective intentions. Can we reclaim the visionary potential of these tools from the grip of capital and control?

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app